妫f牠銆�
閺堢喎鍨�: 瀵邦喕淇婇弬鍥╃彿 閸︺劎鍤庢稊锔剧潉 鐠у嫭鏋℃稉瀣祰 閸嬨儱鎮嶉弶鍌氱箶 閹躲儱鍨旈柅澶岀椽 閸╄櫣顢呴崠璇差劅 娑撴潙绨ラ崠璇差劅 閼筋垰顒� 鐎涳附濮� 娑擃厼娴楅崠璇差劅 閸楊偆鏁撻幀鏄忣啈
娣囨繂浠�: 閺備即妞� 鐠囧嫯顔� 鐟欏棛鍋� 鐢瓕鐦� 閻ゅ墽姊� 閻ュ洨濮� 閸忚崵鏁� 閻€劏宓� 閹躲倗鎮� 閹儲鏅� 閸嬨儴闊� 缂囧骸顔� 娑撱倖鈧拷 閼叉彃鍔� 閻拷 婵傦拷 閼帮拷 鐏忥拷 閸ユ稑顒� 鐠囪崵澧� 閺囨潙顦�
娑擃厼灏�: 鐢瓕鐦� 閺佹瑦娼� 閹繆鈧拷 娑擃叀宓� 閸栬崵鎮� 娑撴潙绨� 闁藉牓顎� 濮樻垶妫� 閺傚洤瀵� 閽佹ぞ缍� 妤犲本鏌� 閸ユ崘姘� 妞嬬喓鏋� 閼筋垳澧� 閼筋垯绗� 閼筋垰绔� 閺傛媽宓� 閹兼粎鍌� 閼昏鲸鏋�
当前位置: 首页 > 期刊 > 《中国当代医药》 > 2015年第2期 > 正文
编号:12626464
介入治疗在原发性肝癌中的应用(4)

     [9] Dai QS,Gu HL,Ye S,et al.Transarterial chemoembolization vs.conservative treatment for unresectable infiltrating hepatocellular carcinomia:A retrospective comparative study[J].Mol Clin Oncol,2014,2(6):1047-1054.

    [10] 郝希山,魏于全.肿瘤学[M].北京:人民卫生出版社,2010:322.

    [11] Lau WY,Sangro B,Chen PJ,et al.Treatment for hepatocellular carcinoma with portal vein tumor thrombosis:the emerging role for radioembilization using Yttrium-90[J].Oncology,2013,84(5):311-318.

    [12] 柯传庆,彭恩兰,彭秋平,等.TACE与γ刀治疗原发性肝癌时序探讨[J].现代肿瘤医学,2014,22(6):1372-1374.

    [13] Frenette CT,Osorio RC,Stark J,et al.Conventional TACE and drug-eluting bead TACE as locoregional therapy before orthotopic liver transplantation:comparison of explant pathologic response[J].Transplantation,2014,98(7):781-787.

    [14] Yamagami T,Yoshimatsu R,Ishikawa M,et al.Transcatheter arterial chemoembolization with an interventional-CT system for recurrent hepatocellular carcinoma after living donor liver transplantation[J].Hepatogastroenterology,2014, 61(133):1387-1392.

    [15] 刘会春.中国原发性肝癌治疗指南解读[J].肝胆外科杂志,2014,21(1):12-14.

    [16] 陈岚芬,李丹丹,黄进,等.超声引导单极冷循环射频消融联合TACE治疗肝癌的对比研究[J].中国超声医学杂志,2014,30(3):238-242.

    [17] Kogut MJ,Chewning RH,Harris WP,et al.Postembolization syndrome after hepatic transarterial chemoembolization:effct of prophylactic steroids on postprocedure medication requirements[J].J Vasc Interv Radiol,2013,24(3):326-331.

    [18] 张大海,顾伟中,叶强,等.原发性肝癌TACE治疗后影响发热的因素[J].介入放射学杂志,2001,10(3):146-148.

    [19] 张帅,倪才方,李智,等.原发性肝癌TACE后合并肝癌破裂八例[J].介入放射学杂志,2014,23(5):437-440.

    [20] Ikeda M.Reactivation of hepatitis B virus in patients receiving chemotherapy[J].Jpn J Clin Oncol,2013,43(5):8-16.

    [21] Perrillo RP.Reactivatrd hepatitis B due to medical interventions:the clinical spectrum expands[J].Antivir Ther,2011, 16(7):947-949.

    [22] 韩聚强,范公忍,任永强,等.不同微创介入治疗原发性肝癌对机体T细胞免疫功能的影响[J].介入放射学杂志,2014,23(3):218-221.

    [23] Tsoulfas G,Agorastou P,Tooulias A,et al.Current and future challenges in the surgical treatment of hepatocellular caicinoma: a review[J].Int Surg,2014,99(6):779-786.

    [24] Yi HM,Zhang W,Ai X,et al.Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma conforming to the Milan criteria: systemic review and meta-analysis[J].Int J Clin Exp Med,2014,7(10):3150-3163.

    [25] Jazieh KA,Arabi M,Khankan AA,et al.Transarterial therapy:An evoling treatment modality of hepatocellular carcinoma[J].Saudi J Gastroenterol,2014,20(6):333-341. (辛晟梁)
上一页1 2 3 4 5下一页
    信息仅供参考,不构成任何之建议、推荐或指引。文章版权属于原著作权人,若您认为此文不宜被收录供大家免费阅读,请邮件或电话通知我们,我们收到通知后,会立即将您的作品从本网站删除。

   微信文章  关注百拇  评论几句  搜索更多   推存给朋友   加入收藏